Your browser doesn't support javascript.
loading
Enhanced Ca2+-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial Fibrillation.
Heijman, Jordi; Zhou, Xiaobo; Morotti, Stefano; Molina, Cristina E; Abu-Taha, Issam H; Tekook, Marcel; Jespersen, Thomas; Zhang, Yiqiao; Dobrev, Shokoufeh; Milting, Hendrik; Gummert, Jan; Karck, Matthias; Kamler, Markus; El-Armouche, Ali; Saljic, Arnela; Grandi, Eleonora; Nattel, Stanley; Dobrev, Dobromir.
Affiliation
  • Heijman J; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • Zhou X; Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, the Netherlands (J.H.).
  • Morotti S; First Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (X.Z.).
  • Molina CE; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, Germany (X.Z.).
  • Abu-Taha IH; Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention of Cardiovascular Diseases, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China (X.Z.).
  • Tekook M; Department of Pharmacology, University of California, Davis (S.M., E.G.).
  • Jespersen T; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • Zhang Y; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Germany (C.E.M.).
  • Dobrev S; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • Milting H; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • Gummert J; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (T.J., A.S.).
  • Karck M; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • Kamler M; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
  • El-Armouche A; Erich and Hanna Klessmann Institute, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany (H.M., J.G.).
  • Saljic A; Erich and Hanna Klessmann Institute, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany (H.M., J.G.).
  • Grandi E; Department of Cardiac Surgery, Heidelberg University Hospital, Germany (M. Karck).
  • Nattel S; Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Germany (M. Kamler).
  • Dobrev D; Institute of Pharmacology, Dresden University of Technology, Germany (A.E.-A.).
Circ Res ; 132(9): e116-e133, 2023 04 28.
Article in En | MEDLINE | ID: mdl-36927079
BACKGROUND: Small-conductance Ca2+-activated K+ (SK)-channel inhibitors have antiarrhythmic effects in animal models of atrial fibrillation (AF), presenting a potential novel antiarrhythmic option. However, the regulation of SK-channels in human atrial cardiomyocytes and its modification in patients with AF are poorly understood and were the object of this study. METHODS: Apamin-sensitive SK-channel current (ISK) and action potentials were recorded in human right-atrial cardiomyocytes from sinus rhythm control (Ctl) patients or patients with (long-standing persistent) chronic AF (cAF). RESULTS: ISK was significantly higher, and apamin caused larger action potential prolongation in cAF- versus Ctl-cardiomyocytes. Sensitivity analyses in an in silico human atrial cardiomyocyte model identified IK1 and ISK as major regulators of repolarization. Increased ISK in cAF was not associated with increases in mRNA/protein levels of SK-channel subunits in either right- or left-atrial tissue homogenates or right-atrial cardiomyocytes, but the abundance of SK2 at the sarcolemma was larger in cAF versus Ctl in both tissue-slices and cardiomyocytes. Latrunculin-A and primaquine (anterograde and retrograde protein-trafficking inhibitors) eliminated the differences in SK2 membrane levels and ISK between Ctl- and cAF-cardiomyocytes. In addition, the phosphatase-inhibitor okadaic acid reduced ISK amplitude and abolished the difference between Ctl- and cAF-cardiomyocytes, indicating that reduced calmodulin-Thr80 phosphorylation due to increased protein phosphatase-2A levels in the SK-channel complex likely contribute to the greater ISK in cAF-cardiomyocytes. Finally, rapid electrical activation (5 Hz, 10 minutes) of Ctl-cardiomyocytes promoted SK2 membrane-localization, increased ISK and reduced action potential duration, effects greatly attenuated by apamin. Latrunculin-A or primaquine prevented the 5-Hz-induced ISK-upregulation. CONCLUSIONS: ISK is upregulated in patients with cAF due to enhanced channel function, mediated by phosphatase-2A-dependent calmodulin-Thr80 dephosphorylation and tachycardia-dependent enhanced trafficking and targeting of SK-channel subunits to the sarcolemma. The observed AF-associated increases in ISK, which promote reentry-stabilizing action potential duration shortening, suggest an important role for SK-channels in AF auto-promotion and provide a rationale for pursuing the antiarrhythmic effects of SK-channel inhibition in humans.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Circ Res Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Circ Res Year: 2023 Type: Article